Large-scale testing (Phase 3)Study completedNCT01964391
What this trial is testing
Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
Who this might be right for
Breast Cancer
Hoffmann-La Roche 174